Gerald Proehl, Director at Qualigen Therapeutics, holds 3.18M shares in Dermata Therapeutics (Ticker: DRMA), holds 1.50K shares in Tenax Therapeutics (Ticker: TENX), holds 50.00K shares in Qualigen Therapeutics (Ticker: QLGN). Most recently, Gerald Proehl Bought ― shares of Dermata Therapeutics on Nov 26, 2021 for an estimated value of 48.00K.